VIVO BIO TECH LTD. Share Price
VIVO BIO TECH LTD. Share Price Today
As of 5 Jul 2026, VIVO BIO TECH LTD. share price is ₹23.55. The stock opened at ₹24.23, compared to its previous close of ₹23.50. During today's trading session, VIVO BIO TECH LTD. share price moved in the range of ₹23.30 to ₹24.23, with an average price of ₹23.77 for the day. Looking at its last 52-week, the stock has touched a low of ₹20.35 and a high of ₹43.35.
VIVO BIO TECH LTD. Returns Calculator
VIVO BIO TECH LTD. Shareholder Returns
VIVO BIO TECH LTD. Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
VIVO BIO TECH LTD. Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹46.67 | ₹45.45 | ₹52.23 | ₹51.39 |
| Other Income | ₹4.80 | ₹0.04 | ₹0.04 | ₹0.10 |
| Total Revenue | ₹51.48 | ₹45.49 | ₹52.27 | ₹51.49 |
| Total Expenses | ₹42.68 | ₹41.43 | ₹47.65 | ₹47.02 |
| Profit Before Tax | ₹8.79 | ₹4.06 | ₹4.62 | ₹4.47 |
| Tax | ₹1.51 | ₹1.53 | ₹1.97 | ₹2.27 |
| Profit After Tax | ₹7.28 | ₹2.53 | ₹2.65 | ₹2.20 |
| EPS - Basic | ₹4.76 | ₹1.70 | ₹1.78 | ₹1.56 |
| EPS - Diluted | ₹4.76 | ₹1.51 | ₹1.78 | ₹1.56 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹8.79 | ₹4.06 | ₹4.62 | ₹4.47 |
| Income before WC changes | ₹20.70 | ₹21.13 | ₹21.54 | ₹15.91 |
| Change in Assets | ₹5.23 | -₹15.43 | -₹6.15 | ₹1.25 |
| Change in Liabilities | -₹10.56 | ₹12.88 | ₹2.79 | ₹2.93 |
| Change in WC | -₹5.32 | -₹2.55 | -₹3.37 | ₹4.18 |
| Cash flow from Operations | ₹11.83 | ₹15.52 | ₹14.83 | ₹16.64 |
| Cash flow from Investing | -₹15.84 | -₹7.95 | -₹4.00 | -₹51.11 |
| Cash flow from Financing | ₹3.90 | -₹7.56 | -₹11.18 | ₹35.02 |
| Total Cash Flow | -₹0.11 | ₹0.01 | -₹0.34 | ₹0.55 |
| Cash (Start of the year) | ₹1.39 | ₹1.37 | ₹1.71 | ₹1.17 |
| Cash (End of the year) | ₹1.28 | ₹1.39 | ₹1.37 | ₹1.71 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹101.29 | ₹89.90 | ₹91.24 | ₹96.45 |
| Current Assets | ₹41.94 | ₹47.23 | ₹31.79 | ₹26.03 |
| Total Assets | ₹143.23 | ₹137.13 | ₹123.03 | ₹122.49 |
| Current Liabilities | ₹27.84 | ₹37.91 | ₹24.97 | ₹23.18 |
| Net Current Asset | ₹14.10 | ₹9.32 | ₹6.82 | ₹2.85 |
| Non-Current Liabilities | ₹37.49 | ₹44.82 | ₹46.19 | ₹52.18 |
| Equity Capital | ₹77.90 | ₹54.40 | ₹51.87 | ₹47.13 |
| Total Equity & Liabilities | ₹143.23 | ₹137.13 | ₹123.03 | ₹122.49 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹46.67 | ₹44.88 | ₹51.62 | ₹51.39 |
| Other Income | ₹4.80 | ₹0.04 | ₹0.04 | ₹0.09 |
| Total Revenue | ₹51.48 | ₹44.92 | ₹51.66 | ₹51.48 |
| Total Expenses | ₹42.40 | ₹40.86 | ₹47.05 | ₹47.01 |
| Profit Before Tax | ₹9.08 | ₹4.05 | ₹4.61 | ₹4.47 |
| Tax | ₹1.51 | ₹1.53 | ₹1.97 | ₹2.27 |
| Profit After Tax | ₹7.57 | ₹2.52 | ₹2.63 | ₹2.20 |
| EPS - Basic | ₹4.95 | ₹1.69 | ₹1.77 | ₹1.56 |
| EPS - Diluted | ₹4.95 | ₹1.51 | ₹1.77 | ₹1.56 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹9.08 | ₹4.05 | ₹4.61 | ₹4.47 |
| Income before WC changes | ₹20.99 | ₹21.12 | ₹21.52 | ₹15.91 |
| Change in Assets | ₹4.85 | -₹15.01 | -₹6.25 | ₹1.05 |
| Change in Liabilities | -₹9.89 | ₹12.78 | ₹2.79 | ₹2.93 |
| Change in WC | -₹5.04 | -₹2.24 | -₹3.46 | ₹3.98 |
| Cash flow from Operations | ₹11.83 | ₹15.83 | ₹14.73 | ₹16.43 |
| Cash flow from Investing | -₹15.84 | -₹7.95 | -₹4.00 | -₹51.11 |
| Cash flow from Financing | ₹3.90 | -₹7.56 | -₹11.20 | ₹35.04 |
| Total Cash Flow | -₹0.11 | ₹0.32 | -₹0.47 | ₹0.37 |
| Cash (Start of the year) | ₹1.32 | ₹0.99 | ₹1.47 | ₹1.10 |
| Cash (End of the year) | ₹1.21 | ₹1.32 | ₹0.99 | ₹1.47 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹97.97 | ₹86.58 | ₹87.92 | ₹93.12 |
| Current Assets | ₹43.31 | ₹48.22 | ₹32.88 | ₹27.18 |
| Total Assets | ₹141.29 | ₹134.80 | ₹120.81 | ₹120.30 |
| Current Liabilities | ₹27.84 | ₹37.81 | ₹24.97 | ₹23.18 |
| Net Current Asset | ₹15.48 | ₹10.41 | ₹7.92 | ₹4.00 |
| Non-Current Liabilities | ₹35.26 | ₹42.59 | ₹43.96 | ₹49.97 |
| Equity Capital | ₹78.19 | ₹54.40 | ₹51.87 | ₹47.14 |
| Total Equity & Liabilities | ₹141.29 | ₹134.80 | ₹120.81 | ₹120.30 |
About VIVO BIO TECH LTD.
Vivo Bio Tech Limited is an India-based company, which is a comprehensive preclinical clinical research organization (CRO) serving pharmaceutical and biotech firms. It operates in the biotechnology segment. It provides integrated discovery, development & regulatory services to pharmaceutical, agrochemical, industrial chemical, vaccines, nutraceutical & medical device companies. The Company's services include in-Vivo and in-Vitro toxicity studies, pharmacological investigations, pharmacokinetic, toxicokinetic studies, genotoxicity screening and analytical services. It screens and assesses molecules for diverse pharmacological properties. In oncology, it designs syngeneic/xenograft models for anti-cancer agent evaluation. It customizes in-Vivo DMPK studies for rodent and non-rodent models to profile drug candidates. It provides both regulatory and non-regulatory IND-enabling preclinical development services.
VIVO BIO TECH LTD. Financial Highlights
- Revenue: VIVO BIO TECH LTD. reported revenue of ₹53.77 crore in FY26 vs ₹51.47 crore in FY25. It showed an increase of 4.47% on a yearly basis.
- Operating Profit: VIVO BIO TECH LTD. reported an operating profit of ₹4.81 crore in FY26 vs ₹8.79 crore in FY25. It showed a decrease of 45.28% on a year-on-year basis.
- Net Profit: VIVO BIO TECH LTD. reported a net loss of ₹1.71 crore in FY26 vs ₹7.28 crore in FY25. It showed a decrease of 123.49% on a yearly basis.
VIVO BIO TECH LTD. Quarterly Result Highlights
- VIVO BIO TECH LTD. reported revenue of ₹14.23 crore in Mar 2026, compared with ₹13.65 crore in Dec 2025, representing an increase of 4.25% on a quarter-on-quarter (QoQ) basis.
- VIVO BIO TECH LTD. reported an operating profit of ₹0.25 crore in Mar 2026, compared with ₹1.57 crore in Dec 2025, representing a decrease of 84.08% on a quarter-on-quarter (QoQ) basis.
- VIVO BIO TECH LTD. reported a loss of ₹5.16 crore in Mar 2026, compared with ₹1.25 crore in Dec 2025, reflecting a decrease of 512.80% on a QoQ basis.
- The earnings per share (EPS) of VIVO BIO TECH LTD. stood at ₹4.76 during Mar 2026.
Similar Stocks
FAQs on VIVO BIO TECH LTD. Share Price
What is VIVO BIO TECH LTD. share price today?
VIVO BIO TECH LTD. share price is ₹23.55 as on 03 Jul, 2026, 15:16 IST.
How has the VIVO BIO TECH LTD. share price performed in the past?
In the last 1 year, VIVO BIO TECH LTD. delivered a return of -36.33%. The VIVO BIO TECH LTD. share price hit a high of ₹43.35 and low of ₹20.35.
How much is the Mutual Fund shareholding in VIVO BIO TECH LTD. shares?
The Mutual Fund Shareholding in VIVO BIO TECH LTD. was 0.00% at the end of Mar 2026.
What is the the 52-week high and low of VIVO BIO TECH LTD. shares ?
The 52-week high and low of VIVO BIO TECH LTD. share is ₹43.35 and ₹20.35 as of 03 Jul, 2026.
What is the market cap of VIVO BIO TECH LTD.?
The market capitalisation of VIVO BIO TECH LTD. is ₹52.15 Crores as on 03 Jul, 2026.
What are the stock symbols of VIVO BIO TECH LTD.?
The stock symbol of VIVO BIO TECH LTD. is 511509 on the BSE, and the ISIN is INE380K01017.
What was yesterday's closing price for VIVO BIO TECH LTD. shares ?
VIVO BIO TECH LTD. shares closed yesterday at ₹23.50 on BSE
How to buy VIVO BIO TECH LTD. shares?
To buy VIVO BIO TECH LTD. shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy VIVO BIO TECH LTD. shares on Holidays?
No, shares of VIVO BIO TECH LTD. or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell VIVO BIO TECH LTD. shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of VIVO BIO TECH LTD.?
The PE and PB ratio of VIVO BIO TECH LTD. is -30.52 and 0.57 respectively, as on 03 Jul, 2026, 15:16 IST.